WO2002010198A3 - Polynucleotides and polypeptides - Google Patents
Polynucleotides and polypeptides Download PDFInfo
- Publication number
- WO2002010198A3 WO2002010198A3 PCT/GB2001/003390 GB0103390W WO0210198A3 WO 2002010198 A3 WO2002010198 A3 WO 2002010198A3 GB 0103390 W GB0103390 W GB 0103390W WO 0210198 A3 WO0210198 A3 WO 0210198A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides
- polypeptides
- relates
- sequences
- mediated
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 210000003979 eosinophil Anatomy 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002227496A AU2002227496A8 (en) | 2000-07-31 | 2001-07-30 | Polynucleotides and polypeptides |
AU2002227496A AU2002227496A1 (en) | 2000-07-31 | 2001-07-30 | Polynucleotides and polypeptides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0018700.5 | 2000-07-31 | ||
GB0018700A GB0018700D0 (en) | 2000-07-31 | 2000-07-31 | Polynucleotides and polypeptides |
GB0031021.9 | 2000-12-19 | ||
GB0031021A GB0031021D0 (en) | 2000-07-31 | 2000-12-19 | Polynucleotides and polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002010198A2 WO2002010198A2 (en) | 2002-02-07 |
WO2002010198A3 true WO2002010198A3 (en) | 2007-10-18 |
Family
ID=26244763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/003390 WO2002010198A2 (en) | 2000-07-31 | 2001-07-30 | Polynucleotides and polypeptides |
Country Status (3)
Country | Link |
---|---|
AU (2) | AU2002227496A8 (en) |
GB (1) | GB0031021D0 (en) |
WO (1) | WO2002010198A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217799B2 (en) | 2000-08-28 | 2007-05-15 | Agensys, Inc. | Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer |
WO2021248053A2 (en) * | 2020-06-04 | 2021-12-09 | Godx, Inc. | Point-of-care sars-cov-2 virus diagnostic device and methods of use thereof |
-
2000
- 2000-12-19 GB GB0031021A patent/GB0031021D0/en not_active Ceased
-
2001
- 2001-07-30 WO PCT/GB2001/003390 patent/WO2002010198A2/en active Application Filing
- 2001-07-30 AU AU2002227496A patent/AU2002227496A8/en not_active Abandoned
- 2001-07-30 AU AU2002227496A patent/AU2002227496A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
BRENNER V ET AL: "Analysis of cellular adhesion by microarray expression profiling", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 250, no. 1-2, 1 April 2001 (2001-04-01), pages 15 - 28, XP004230692, ISSN: 0022-1759 * |
DATABASE EMBL [online] 14 March 2000 (2000-03-14), BIRREN B. ET AL., XP002190683, retrieved from EBI Database accession no. AC025342 * |
KILTY I C ET AL: "Studies of differential gene expression in clinically derived eosinophil populations.", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 29, no. 12, December 1999 (1999-12-01), pages 1671 - 1680, XP001038352, ISSN: 0954-7894 * |
TEMPLE R ET AL.: "Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes.", AM J RESPIR CELL MOL BIOL, vol. 25, no. 4, October 2001 (2001-10-01), pages 425 - 433, XP001037077 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002227496A1 (en) | 2002-02-13 |
WO2002010198A2 (en) | 2002-02-07 |
AU2002227496A8 (en) | 2007-12-20 |
GB0031021D0 (en) | 2001-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001057081A3 (en) | Narc-1, subtilase-like homologs | |
WO2001055307A3 (en) | Nucleic acids, proteins, and antibodies | |
WO2000006085A3 (en) | Compounds and methods | |
WO2001054472A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001055306A3 (en) | Nucleic acids, proteins, and antibodies | |
WO2001068859A3 (en) | Il-17 receptor like molecules and uses thereof | |
WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
WO2002086076A3 (en) | Polynucleotides and polypeptides associated with the nf-kb pathway | |
WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
WO2004081229A3 (en) | Use of bv8 and/or eg-vegf to promote hematopoiesis | |
WO2004100886A3 (en) | POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY | |
WO2003020892A3 (en) | Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY | |
WO2002010198A3 (en) | Polynucleotides and polypeptides | |
WO2001055168A8 (en) | Nucleic acids, proteins and antibodies | |
WO1999030670A3 (en) | Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof | |
WO2004007536A3 (en) | Interactions of the epstein-barr virus protein ebna1, and uses thereof | |
EP1130122A3 (en) | Methods for the diagnosis of polymorphisms in the human EP1-R gene | |
IL155687A0 (en) | Polynucleotides encoding hlrrsi1 polypeptides | |
WO2003025197A3 (en) | Mutant sh3-binding protein compositions and methods | |
WO2000039136A3 (en) | Human brainiac-5 | |
WO2002068687A3 (en) | Function and application of tob gene in central nervous system of mammal | |
WO2002000826A3 (en) | A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide | |
WO2001033220A3 (en) | The use of the area postreama to identify therapeutic compounds | |
WO2001055167A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001096526A3 (en) | A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |